ACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.

ANNALS OF NEUROLOGY, published by Wiley, stands as a leading journal in the field of neurology, renowned for its rigorous peer-reviewed articles that contribute significantly to the understanding of neurological disorders and advances in clinical practices. With an impressive impact factor and ranked Q1 in both neurology and clinical neurology categories, this journal positions itself among the top repositories of cutting-edge research, indexed in Scopus with exemplary ranks in the 98th and 97th percentiles respectively. Since its inception in 1977 and with a commitment to excellence extending to 2024 and beyond, ANNALS OF NEUROLOGY aims to disseminate groundbreaking studies and foster dialogue within the academic community, making it an essential resource for researchers, healthcare professionals, and students dedicated to neurology. Although it does not currently offer open access, its accessibility through institutional subscriptions facilitates widespread scholarly engagement.

NEUROIMAGING CLINICS OF NORTH AMERICA is a premier peer-reviewed journal published by W B SAUNDERS CO-ELSEVIER INC, focusing on the evolving field of neuroimaging and its applications in clinical practice. Established in 1993, this journal has become a pivotal resource for researchers, professionals, and students alike, providing in-depth articles, reviews, and case studies that address both cutting-edge advancements and standard practices in neuroimaging. With its impressive credentials, ranking in the top quartiles of various medical categories—including Q2 in Medicine (Miscellaneous) and Q2 in Radiology, Nuclear Medicine, and Imaging—the journal is vital for advancing knowledge and clinical applications in the disciplines of neurology and radiology. Although it does not offer open access, the journal maintains a robust reputation with a broad readership, embodying a commitment to excellence in medical literature. The ISSN number is 1052-5149 and the E-ISSN number is 1557-9867, ensuring the accessibility and dissemination of high-quality neuroimaging research.

The Lancet Neurology is a premier academic journal published by Elsevier Science Inc, specializing in the field of neurology. With a robust impact factor that signifies its authoritative presence, it consistently ranks in the Q1 category for clinical neurology according to the 2023 standards, positioning itself as the leading journal in its domain, ranking #1 out of 400 in Scopus' neurology rankings and placing in the 99th percentile. Since its establishment in 2002, it has provided a vital platform for disseminating innovative research and clinical advances related to neurological disorders. The journal’s precise focus includes cutting-edge studies on neurodegenerative diseases, stroke, epilepsy, and neuroimaging, which are essential for advancing clinical practice and improving patient outcomes. While it does not offer open access, readers can find high-impact research published monthly, making it indispensable for practitioners, researchers, and students eager to stay at the forefront of neurological science.

Annals of Clinical and Translational Neurology is a premier journal published by WILEY, focusing on the fields of neurology and neuroscience. Since its inception in 2014, it has established itself as an Open Access platform, providing unrestricted access to cutting-edge research to promote scientific collaboration and innovation. With an impressive Impact Factor residing in the top quartile (Q1) for both clinical neurology and miscellaneous neuroscience in 2023, this journal ranks #52 out of 400 in the Neurology category and #22 out of 113 in General Neuroscience, indicating its significant contribution to the field. The journal welcomes submissions that address emerging trends and challenges in translational neurology, aiming to bridge the gap between laboratory research and clinical practice. By disseminating high-quality research and fostering a community of scholars, Annals of Clinical and Translational Neurology plays a vital role in advancing our understanding of neurological disorders and improving patient care worldwide.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Neurohospitalist is a premier journal dedicated to advancing the field of clinical neurology, published by SAGE Publications Ltd. With an ISSN of 1941-8744 and an E-ISSN of 1941-8752, this journal caters to the growing demand for high-quality research and discussions around neurological emergencies and hospital-based care. Established in 2011 and slated to continue through 2024, Neurohospitalist aims to foster comprehensive and impactful studies that contribute to clinical practice and patient outcomes in neurology. It holds a respectable Q3 categorization in Neurology (clinical) for 2023, indicating its valuable contributions amidst a competitive landscape. Although it does not offer open access options, researchers and professionals can access essential findings that push the boundaries of contemporary neurology. By bringing together innovative research, expert reviews, and case studies, Neurohospitalist serves as a vital resource for those engaged in the dynamics of neurological care, encouraging the exchange of knowledge among clinicians, researchers, and students alike.

SEMINARS IN NEUROLOGY is a leading journal in the field of neurology, published by THIEME MEDICAL PUBL INC. With its ISSN 0271-8235 and E-ISSN 1098-9021, this esteemed journal has been a vital resource for the neurology community since its inception in 1984. Covering critical advancements and contemporary issues in both neurology and clinical neurology, it holds a reputable position in the Q2 category for both disciplines as of 2023. The journal ranks #164 out of 400 in clinical neurology, indicating its significant contribution to the field, and is indexed in Scopus for robust academic exposure. SEMINARS IN NEUROLOGY offers a platform for authors to disseminate groundbreaking research and reviews, ultimately enhancing knowledge and practice in neurological sciences. With unrestricted access options, it seeks to engage researchers, practitioners, and students, fostering a comprehensive understanding of the complexities of neurological disorders and therapies.

PRACTICAL NEUROLOGY, published by the esteemed BMJ PUBLISHING GROUP, is a prominent journal in the fields of neurology and medicine, significantly impacting clinical practice since its inception in 2001. With an ISSN of 1474-7758 and an e-ISSN of 1474-7766, this UK-based journal reaches a diverse audience of researchers, clinicians, and students who seek to advance their understanding of neurological conditions and patient care strategies. Ranked in the second quartile (Q2) in both the miscellaneous medicine and clinical neurology categories for 2023, and positioned in the 47th percentile among its peers, PRACTICAL NEUROLOGY provides a platform for high-quality research that bridges the gap between laboratory findings and clinical applications. The journal's commitment to disseminating valuable information through peer-reviewed articles ensures that readers are equipped with the latest insights and practical knowledge necessary for improving outcomes in neurology. While access options are not currently open, the journal remains a vital resource for professionals striving to stay at the forefront of neurological research and clinical practice.

JOURNAL OF THE NEUROLOGICAL SCIENCES, published by Elsevier, is a leading academic journal that has been at the forefront of neurology research since its inception in 1964. With a robust scope covering both clinical and experimental neurological sciences, this journal serves as an invaluable resource for researchers, practitioners, and students in the field. The journal is indexed with an impressive Q2 ranking in Neurology and a remarkable Q1 status in Clinical Neurology as of 2023, reflecting its high impact and relevance in the medical community. The journal's Scopus rankings further emphasize its significance, holding the 69th position in clinical neurology and 35th in neuroscience, marking it in the top 82nd percentile of its peers. While the journal operates under a traditional subscription model, it continues to offer a platform for groundbreaking research and comprehensive reviews that advance our understanding of neurological disorders. Researchers and clinicians alike will find the JOURNAL OF THE NEUROLOGICAL SCIENCES an essential contribution to the literature, paving the way for innovations in clinical practices and therapeutic strategies.